[HTML][HTML] Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment
S Mazza, C Frigerio, D Alfieri, A Mauro, F Torello Viera… - Medicina, 2024 - mdpi.com
Background and Objectives: Serum alpha-fetoprotein (AFP) is a recognized affordable
oncological marker in patients with hepatocellular carcinoma (HCC). However, AFP's …
oncological marker in patients with hepatocellular carcinoma (HCC). However, AFP's …
ASO Author Reflections: α-Fetoprotein in Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): Beyond Diagnosis to Prognostication
LQ Yao, GY Lv, T Yang - Annals of Surgical Oncology, 2024 - Springer
Hepatocellular carcinoma (HCC) is a major global health concern. 1 According to the
Barcelona Clinic Liver Cancer (BCLC) algorithm, tumor burden and liver function, but not …
Barcelona Clinic Liver Cancer (BCLC) algorithm, tumor burden and liver function, but not …